1
Back to Glossary
Asset
Pharmacovigilance Glossary

Black Triangle

Imagine buying a brand-new model of a washing machine. It passed every factory test perfectly, but the manufacturer still puts a bright sticker on it asking you to report any weird noises during your first year of regular use. The Black Triangle is that exact same sticker, just for newly approved medicines.

Where do you actually see it?

It is literally an inverted black triangle (▼) printed right on the medicine's packaging and on the informational leaflet inside the box, usually right next to the phrase "subject to additional monitoring."

Hover over the graphic to see why →
Why the triangle? It usually means the drug contains a new active substance, is a biologic (like a vaccine), or was approved quickly. We need doctors and patients to hyper-report any weird side effects!

What does it mean in plain English?

The Black Triangle is basically a flag for surveillance. When a new drug gets approved, it has usually only been tested on a few thousand people in clinical trials. That is enough to prove it works and is generally safe, but it isn't enough to catch a side effect that only happens to 1 in 100,000 people.

By putting the triangle on the box, the regulators (like the EMA in Europe) are deliberately lowering the bar for reporting. They are asking doctors, pharmacists, and patients: "Hey, if you feel anything weird after taking this, even if you just have a funny taste in your mouth, tell us." It helps safety scientists spot rare patterns incredibly fast.

It doesn't last forever. Most medicines only carry the Black Triangle for about five years. Once the regulators are happy they have enough real-world safety data, they take the training wheels off and the triangle is removed.

Who gets the triangle?

Not every medicine needs one. A drug usually gets assigned the Black Triangle if it fits into one of these buckets:

  • It is brand new: It contains an active ingredient that regulators haven't seen before.
  • It is complex to make: Biological medicines (like vaccines or antibodies) have natural variability, so we watch them closer.
  • It was rushed for a good reason: If a drug was given conditional or accelerated approval (because it treats a severe disease with no other cure), regulators collect the long-term data after it launches.

Common Misconceptions

Myth

"Oh no, my doctor prescribed me a drug with a black triangle on it! Does this mean it's risky, experimental, or unsafe to take?"

Truth

Not at all. The triangle is about the amount of data we have, not the danger of the drug. Perfectly safe, low-risk medicines get it simply because they are new to the market. It means the safety system is working exactly as it should!